0
Article |

Newborn Hepatitis B Immunization Rates in Primary Care Practices FREE

John G. Bertolino, MD, MSPH
Arch Pediatr Adolesc Med. 1996;150(11):1173-1176. doi:10.1001/archpedi.1996.02170360063010.
Text Size: A A A
Published online

Objectives:  To assess the hepatitis B immunization rate and to identify the reasons for an incomplete immunization series in newborns and infants seen in primary care practices.

Design:  An inception cohort study enrolling newborns and infants and assessing their hepatitis B immunization status at 9 and 18 months of age.

Setting:  Six primary care offices, most in rural environments.

Patients:  All newborns and infants seen at 1 of 6 offices.

Intervention:  Infants born between January 1, 1993, and September 30, 1994, were followed up through June 30, 1995. Hepatitis B immunization status and the reasons for an incomplete status were recorded at each visit.

Main Outcome Measures:  Hepatitis B immunization rates at 9 and 18 months of age, and the reasons for immunization failure.

Results:  The immunization rates of infants aged 9 and 18 months were 60% and 77%, respectively. The most common reasons for inadequate immunization of the 247 infants followed up through age 18 months were patient transfer (7%), failing to return for a scheduled visit (4%), and guardians refusing the immunization (4%). Failure to return for a scheduled visit was the reason for the incomplete immunization in 13% of the 9-month-old infants. Immunization of these patients was the most important factor in the higher immunization rate at 18 months of age. By the age of 18 months, 95% of all infants had received at least 2 doses of the hepatitis B immunization.

Conclusions:  A hepatitis B newborn immunization rate of 77% by age 18 months was achieved in a primary care office setting. Barriers to complete immunization by the age of 18 months include patient transfer, patient failure to return, and parental refusal of immunization.Arch Pediatr Adolesc Med. 1996;150:1173-1176

REFERENCES

Centers for Disease Control.  Hepatitis B virus, a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee . MMWR Morb Mortal Wkly Rep . 1991;;40:1-25.
Hadler SC, Margolis HS.  Hepatitis B immunization: vaccine types, efficacy, and indications for immunization . In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases . Boston, Mass: Blackwell Scientific Publications Inc; 1992;:282-308.
Margolis HS, Coleman PJ, PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA.  Prevention of hepatitis B virus transmission by immunization . JAMA . 1995;;274: 1201-1208.
Centers for Disease Control.  Reported vaccine-preventable diseases—United States, 1993, and the Childhood Immunization Initiative . MMWR Morb Mortal Wkly Rep . 1994;;43:57-60.
Dobson S, Scheifele D, Bell A.  Assessment of a universal school-based hepatitis-B vaccination program . JAMA . 1995;;274:1209-1213.
Centers for Disease Control.  Vaccination coverage of 2-year-old children United States, 1993 . MMWR Morb Mortal Wkly Rep . 1994;;43:705-709.
Combs SP, Walter EB, Drucker RP, Clements DA.  Removing a major barrier to universal hepatitis B immunization in infants . Arch Pediatr Adolesc Med . 1996;; 150:112-114.
Freed GL, Bordley WC, Clark Konrad TR.  Universal hepatitis B immunizaof infants: reactions of pediatricians and family physicians over time . Pediatrics . 1994;;93:747-751.
Kraus DM, Campbell MM, Marcinak JF.  Evaluation of universal hepatitis B immunization practices of Illinois pediatricians . Arch Pediatr Adolesc Med . 1994;; 148:936-942.
Committee on Infectious Diseases.  Universal hepatitis B immunization . Pediatrics . 1995;;89:795-800.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Centers for Disease Control.  Hepatitis B virus, a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee . MMWR Morb Mortal Wkly Rep . 1991;;40:1-25.
Hadler SC, Margolis HS.  Hepatitis B immunization: vaccine types, efficacy, and indications for immunization . In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases . Boston, Mass: Blackwell Scientific Publications Inc; 1992;:282-308.
Margolis HS, Coleman PJ, PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA.  Prevention of hepatitis B virus transmission by immunization . JAMA . 1995;;274: 1201-1208.
Centers for Disease Control.  Reported vaccine-preventable diseases—United States, 1993, and the Childhood Immunization Initiative . MMWR Morb Mortal Wkly Rep . 1994;;43:57-60.
Dobson S, Scheifele D, Bell A.  Assessment of a universal school-based hepatitis-B vaccination program . JAMA . 1995;;274:1209-1213.
Centers for Disease Control.  Vaccination coverage of 2-year-old children United States, 1993 . MMWR Morb Mortal Wkly Rep . 1994;;43:705-709.
Combs SP, Walter EB, Drucker RP, Clements DA.  Removing a major barrier to universal hepatitis B immunization in infants . Arch Pediatr Adolesc Med . 1996;; 150:112-114.
Freed GL, Bordley WC, Clark Konrad TR.  Universal hepatitis B immunizaof infants: reactions of pediatricians and family physicians over time . Pediatrics . 1994;;93:747-751.
Kraus DM, Campbell MM, Marcinak JF.  Evaluation of universal hepatitis B immunization practices of Illinois pediatricians . Arch Pediatr Adolesc Med . 1994;; 148:936-942.
Committee on Infectious Diseases.  Universal hepatitis B immunization . Pediatrics . 1995;;89:795-800.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.